AI assistant
Cipla Ltd. — Regulatory Filings 2020
Jun 12, 2020
59275_rns_2020-06-12_6d585b92-2343-48a7-9ba8-fd59e8d541da.pdf
Regulatory Filings
Open in viewerOpens in your device viewer

12th June, 2020
- (1) BSE Ltd Listing Department Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001
- (2) National Stock Exchange of India Ltd Listing Department Exchange Plaza, 5th floor, Plot no. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051
Scrip Code: 500087
Scrip Code: CIPLA
(3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg
Sub: Disclosure of related party transactions for the half year ended 31st March, 2020
Dear Sir/Madam,
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards, for the half year ended 31st March, 2020.
This disclosure is also being uploaded on the website of the Company i.e. www.cipla.com.
This is for your information and record.
Thanking you,
Yours faithfully, For Cipla Limited

Rajendra Chopra Company Secretary
Prepared by: Pratiksha Mangaonkar
Consolidated disclosure of related party transaction and balances for the half yearly ended 31st March, 2020
Information on related party transactions as required by Ind AS-24 - 'Related Party Disclosures' are given below:
List of related parties
A. Associate
Stempeutics Research Private Limited Avenue Therapeutics, Inc. Brandmed (Pty) Ltd (w.e.f. 24th April, 2019) AMPSolar Power Systems Private Limited (w.e.f. 12th June, 2019)
B. Key management personnel
Ms. Samina Hamied - Executive Vice-Chairperson Mr. Umang Vohra – Managing Director and Global Chief Executive Officer Mr. Kedar Updhaye - Global Chief Financial Officer Dr. Raghunathan Ananthanarayanan - President and Global Chief Operating Officer (Upto 31st December, 2019)
C. Non executive chairman and non executive vice chairman
Dr. Y. K. Hamied, Chairman Mr. M. K. Hamied, Vice Chairman
D. Non executive directors
Mr. Ashok Sinha Mr. Adil Zainulbhai Ms. Punita Lal Ms. Naina Lal Kidwai Mr. Peter Lankau (Upto 30th June,2019) Dr. Peter Mugyenyi Mr. S Radhakrishnan
E. Entities over which key management personnel are able to exercise significant influence
Cipla Foundation Chest Research Foundation (Formerly known as Hamied Foundation upto 14th October, 2019) Cipla Cancer and AIDS Foundation
F. Trust over which entity has control/significant influence
Cipla Limited Employees Provident Fund Cipla Limited Employees Gratuity Fund Cipla Employees Stock Option Trust Cipla Health Employees Stock Option Trust
| ₹ Crore | |||
|---|---|---|---|
| Particulars | For the half year ended | ||
| 31st March, 2020 | |||
| A. | Remuneration (Including sitting fees)* | ||
| Dr. Y.K. Hamied | 1.02 | ||
| Mr. M.K. Hamied | 1.04 | ||
| Ms. Samina Hamied | 3.39 | ||
| Mr. Umang Vohra | 7.82 | ||
| Mr. S.Radhakrishnan | 1.04 | ||
| Mr. Kedar Upadhye | 1.91 | ||
| Mr. Ashok Sinha | 0.24 | ||
| Mr. Adil Zainulbhai | 0.24 | ||
| Ms. Punita Lal | 0.20 | ||
| Ms. Naina Lal Kidwai | 0.23 | ||
| Dr. Peter Mugyenyi | 0.26 | ||
| Dr. Raghunathan Ananthanarayanan | (6.69) | ||
| 10.70 |
* Expenses towards gratuity, compensated absences and premium paid for group health insurance has not been considered in above information as a separate actuarial valuation/premium paid are not available.
| B. Testing and analysis charges paid | ||
|---|---|---|
| Stempeutics Research Private Limited | 1.08 | |
| 1.08 | ||
| C. Freight charges paid | ||
| Stempeutics Research Private Limited | 0.02 | |
| 0.02 | ||
| D. | Contribution to provident fund and other fund | |
| Cipla Limited Employees Gratuity Fund | 15.00 | |
| Cipla Limited Employees Provident Fund | 20.39 | |
| 20.39 | ||
| E. | Donations given | |
| Cipla Foundation | 19.08 | |
| Chest Research Foundation | 2.00 | |
| 21.08 | ||
| F. Rent received | ||
| Dr. Y.K. Hamied (₹ 10,020/-) | 0.00 | |
| 0.00 | ||
| G. Reimbursement of operating/other expenses | ||
| Stempeutics Research Private Limited | 0.27 | |
| 0.27 | ||
| H. Equity Investment made during the period | ||
| AMPSolar Power Systems Private Limited | 0.09 | |
| 0.09 | ||
| I. Investment in compulsory convertible debentures | 8.91 | |
| AMPSolar Power Systems Private Limited | ||
| 8.91 |
| ₹ Crore | ||
|---|---|---|
| Particulars | For the half year ended | |
| 31st March, 2020 | ||
| J. Payable to key management personnel and non executive directors | ||
| Dr. Y.K. Hamied | 2.00 | |
| Mr. M.K. Hamied | 2.00 | |
| Ms. Samina Hamied | 2.30 | |
| Mr. Umang Vohra | 4.00 | |
| Mr. S.Radhakrishnan | 2.00 | |
| Mr. Kedar Upadhye | 0.90 | |
| Mr. Ashok Sinha | 0.40 | |
| Mr. Adil Zainulbhai | 0.36 | |
| Ms. Punita Lal | 0.35 | |
| Ms. Naina Lal Kidwai | 0.35 | |
| Mr. Peter Lankau | 0.10 | |
| Dr. Peter Mugyenyi | 0.41 | |
| 15.17 | ||
| K. Contribution payable to provident fund | ||
| Cipla Employees Provident Fund | 10.37 | |
| 10.37 | ||
| L. Payable to gratuity fund | ||
| Cipla Limited Employees Gratuity Fund | 27.94 | |
| 27.94 | ||
| M. Dividend paid | ||
| Dr. Y.K. Hamied | 65.59 | |
| Mr. M.K. Hamied | 13.83 | |
| Ms. Samina Hamied | 7.16 | |
| Mr. Umang Vohra | 0.10 | |
| Mr. S.Radhakrishnan | 0.08 | |
| Mr. Kedar Upadhye | 0.02 | |
| 86.78 |